Intercontinental Exchange $2.5 billion notes offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered debt offering by Intercontinental Exchange, Inc. of $1.25 billion aggregate principal amount of…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Toyota Motor Credit $3 billion notes offering
Davis Polk advised Toyota Motor Credit Corporation in connection with an SEC-registered offering of $1.25 billion aggregate principal amount of 1.150% medium-term notes, Series B due 2022, …
DexCom $1.05 billion convertible notes offering
Davis Polk advised the representatives of several initial purchasers in connection with a Rule 144A offering by DexCom, Inc. of $1.05 billion aggregate principal amount of its 0.250%…
Fiserv $2 billion senior notes offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering by Fiserv, Inc. of $1 billion principal amount…
Flex $750 million notes offering
Davis Polk advised the joint book-running managers in connection with a $750 million SEC-registered debt offering by Flex Ltd. The offering consisted of $425 million aggregate…
Callaway Golf $259 million convertible senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Callaway Golf Company of $258.75 million aggregate principal amount of its 2.75% convertible senior…
NeoGenomics $300 million offerings of stock and convertible senior notes
Davis Polk advised the joint book-running managers in connection with concurrent SEC-registered offerings by NeoGenomics, Inc. of 4,400,000 shares of its common stock and $175 million…
DuPont de Nemours $2 billion notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by DuPont de Nemours, Inc. of $2 billion aggregate principal amount of…
BioXcel Therapeutics, Inc. $18.9 Million Common Stock Offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,303,030 shares of its common stock. The common stock is listed on the…
Davis Polk Advises Banco de Crédito del Perú on Its $700 Million and S/2.5 Billion Takedowns under Its MTN Program and Cash Tender Offers
Davis Polk advised Banco de Crédito del Perú in connection with offerings of $700 million aggregate principal amount of 2.700% fixed-rate notes due 2025 and S/2.5 billion 4.650% notes due…